← Leaderboards
Laura Volpicelli-Daley
Emory University
$5,953,167
Attributed
$5,953,167
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,953,167 · 5
By mechanism
R01$3,767,993 · 2
P50$1,274,668 · 1
R56$768,806 · 1
F32$141,700 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Lenora Higginbotham$1,210,894
- James J Lah$46,199,664
- Thomas Spurgeon Wingo$12,227,212
- Junmin Peng$22,963,451
- Ellen J. Hess$12,190,689
Others in their field
Top investigators on “Pathologic”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologicNeuronsMotorProteinsBrainAlpha SynucleinPreventParkinson DiseaseGenesBrain RegionDopaminergic NeuronNew Therapeutic TargetPathologyInjectionsDefectBrain TissueNeuron LossPlayLrrk2 GenePars CompactaImmunohistochemistryAmygdaloid StructureDisease ProgressionLewy Bodies
Grant awards (20)
Role of GlcSph in cognitive deficits in Lewy body dementias$587,393
R01 · FY2025 · AG · contact PI
Role of GlcSph in cognitive deficits in Lewy body dementias$593,379
R01 · FY2024 · AG · contact PI
Role of GlcSph in cognitive deficits in Lewy body dementias$100,000
R01 · FY2024 · AG · contact PI
Role of GlcSph in cognitive deficits in Lewy body dementias$630,971
R01 · FY2023 · AG · contact PI
Role of presynaptic targeting of alpha-synuclein in the pathogenesis of Parkinson's Disease and Dementia with Lewy Bodies$371,250
R01 · FY2022 · NS · contact PI
Core C: Animal Models Core$245,026
P50 · FY2022 · NS · contact PI
Role of presynaptic targeting of alpha-synuclein in the pathogenesis of Parkinson's Disease and Dementia with Lewy Bodies$371,250
R01 · FY2021 · NS · contact PI
Core C: Animal Models Core$245,025
P50 · FY2021 · NS · contact PI
Alpha-synuclein aggregate induced synapse loss is a pathological event contributing to Lewy body dementias$768,806
R56 · FY2020 · NS · contact PI
Role of presynaptic targeting of alpha-synuclein in the pathogenesis of Parkinson's Disease and Dementia with Lewy Bodies$371,250
R01 · FY2020 · NS · contact PI
Core C: Animal Models Core$246,319
P50 · FY2020 · NS · contact PI
Core C: Animal Models Core$48,248
P50 · FY2020 · NS · contact PI
Role of presynaptic targeting of alpha-synuclein in the pathogenesis of Parkinson's Disease and Dementia with Lewy Bodies$371,250
R01 · FY2019 · NS · contact PI
Core C: Animal Models Core$245,025
P50 · FY2019 · NS · contact PI
Role of presynaptic targeting of alpha-synuclein in the pathogenesis of Parkinson's Disease and Dementia with Lewy Bodies$371,250
R01 · FY2018 · NS · contact PI
Core C: Animal Models Core$245,025
P50 · FY2018 · NS · contact PI
Vesicular transport of the amyloid precursor protein$50,428
F32 · FY2006 · AG · contact PI
Vesicular transport of the amyloid precursor protein$36,106
F32 · FY2005 · AG
Vesicular transport of the amyloid precursor protein$12,190
F32 · FY2005 · AG
Vesicular transport of the amyloid precursor protein$42,976
F32 · FY2004 · AG